From a nurse advocacy perspective, how would you advocate for a patient that felt uncomfortable participating in the study
after consent was already given?
Please construct a response based on this question which was based on the response below.
The Institutional Review Board (IRB) is an essential component of research ethics in nursing and population health. The IRB
examines research methods to ensure they are carried out ethically and preserve the rights and welfare of human participants. It also considers the choice of research participants and the likelihood of improper influence, coercion, or exploitation (Altavilla,
Giannuzzi, Lupo, Bonifazi, & Ceci, 2020). Furthermore, the IRB evaluates the research study’s potential hazards and advantages for the participants, their confidentiality, and the informed consent procedure.
Justice, beneficence, and respect are ethical
research considerations concerning population health. Justice is crucial as the research should be conducted transparent, fair, and equitably. Beneficence is the obligation of medical practitioners and researchers to act in the best interests of the
population under study and produce the best outcome. Respect demands protecting the privacy and anonymity of research
participants and treating them with respect and autonomy.
It is crucial to maintain the respect, benefits, and burdens of
research and justice to conduct translational research successfully. The respect for the research persons is preserved by ensuring that study participants have their agency and their rights are upheld. Similarly, the potential benefits and burdens of the study are kept in balance by giving research participants the knowledge they need to decide whether or not to engage in the study. Lastly, justice is demonstrated by ensuring that the investigation is fair and equitable and that all research participants have equal access.
For instance, a nurse studying how anesthesia affects people who have had Cesarean sections (CS) must
observe respect for the research participants by allowing them to leave the study whenever they want. They should also be informed of both its possible risks and rewards. By providing the research participants with clear and unambiguous information
about the medicine and its potential side effects, the potential benefits and burdens of the study must be considered and
balanced (McCradden et al., 2022). Lastly, justice must be maintained by ensuring that all research participants have equal
access to it and that it is carried out fairly and equitably.
References
Altavilla, A., Giannuzzi, V., Lupo, M., Bonifazi, D., & Ceci, A. (2020). Ethical, Legal and Regulatory Issues of Paediatric Translational Research. Call for an Adequate Model of Governance. European Journal of Health Law, 27(3), 213–231. https://doi.org/10.1163/15718093-bja10010
McCradden, M. D., Anderson, J. A., A. Stephenson, E., Drysdale, E., Erdman, L., Goldenberg, A., & Zlotnik Shaul, R. (2022). A Research Ethics Framework for the Clinical Translation of Healthcare Machine Learning. The American Journal of Bioethics, 1–15. https://doi.org/10.1080/15265161.2021.2013977
Last Completed Projects
| topic title | academic level | Writer | delivered |
|---|